Engineering of alcohol dehydrogenase 2 hybrid‐promoter architectures in Pichia pastoris to enhance recombinant protein expression on ethanol

Burcu Gündüz Ergün,Brigitte Gasser,Diethard Mattanovich,Pınar Çalık
DOI: https://doi.org/10.1002/bit.27095
IF: 3.8
2019-07-09
Biotechnology and Bioengineering
Abstract:<p>The aim of this work is to increase recombinant protein expression in <i>Pichia pastoris</i> over the ethanol utilisation pathway under novel‐engineered promoter variants (NEPVs) of <i>alcohol dehydrogenase 2</i> promoter (P<sub><i>ADH2</i></sub>) through the generation of novel regulatory circuits. The NEPVs were designed by engineering of transcription factor binding sites (TFBSs) determined by <i>in silico</i> analyses and manual curation systematically, by: <i><b>(i)</b></i> single‐handedly replacement of specified TFBSs with synthetic motifs for Mxr1, Cat8, and Aca1 binding, and synthetic TATA‐box integration; and, <i><b>(ii)</b></i> nucleosome optimization. P<sub><i>ADH2‐Cat8‐L2</i></sub> and P<sub><i>ADH2‐Cat8‐L1</i></sub> designed by the integration of synthetic Cat8 binding sites were superior, and then P<sub><i>ADH2‐NucOpt</i></sub>. Compared to that with P<sub><i>ADH2</i></sub> at t = 20 h of the fermentations, P<sub><i>ADH2‐Cat8‐L2</i></sub> allowed the highest increase in enhanced green fluorescent protein expression as 4.8‐fold on ethanol and 3.8‐fold on methanol; and, P<sub><i>ADH2‐NucOpt</i></sub> upregulated the expression 1.5‐fold on ethanol and enhanced 3.2‐fold on methanol. Using superior two tools, Cat8‐L2 and NucOpt, we designed P<sub><i>ADH2‐NucOpt‐Cat8‐L2</i></sub>. With P<sub><i>ADH2‐NucOpt‐Cat8‐L2</i></sub>, the expression in the fermentation of ethanol was upregulated 3.7‐fold that is distinctly higher than that with P<sub><i>ADH2‐NucOpt</i></sub> but lower than that with P<sub><i>ADH2‐Cat8‐L2</i></sub>; while on methanol compared to that with P<sub><i>ADH2</i></sub>, the expression was enhanced 8.8‐fold. Extracellular recombinant human serum albumin production was also studied with P<sub><i>ADH2‐Cat8‐L2</i></sub> and P<sub><i>ADH2‐NucOpt</i></sub>, and average recombinant human serum albumin yield (Y<sub>P/X</sub>) on ethanol was 1.13 and 0.38 mg/g<sub>WCW,</sub> respectively; whereas with P<sub><i>ADH2</i></sub>, Y<sub>P/X</sub> was 0.26 mg/g<sub>WCW</sub>. We conclude that as upregulation of transcription and enhanced expression correlate with the sequence of synthetic motifs and their location in the hybrid‐promoter architectures of NEPVs in coordination with trans‐acting factors, which are the design parameters in the engineering of binding sites; the NEPVs generated promising recombinant protein production platforms with a high impact on industrial scale production processes, as well as would open up new avenues for research in <i>P. pastoris</i>.</p><p>This article is protected by copyright. All rights reserved.</p>
biotechnology & applied microbiology
What problem does this paper attempt to address?